Pharmafile Logo

Dedicated

EU flag

Europe wants scientific advice to become pluralistic

Commission endeavours to create a new science committee and reject a single advisor model

- PMLiVE

Takeda strengthens leadership team with business unit director

Craig Adkins takes up the position after being at the firm for ten years

Teva Pharma logo

Teva says chronic migraine drug is ready for phase III

TEV-48125 efficacy “has not previously been achieved”

Can Cinderella save us?

Pharma should pay into antibiotic resistance fund

Claims stem from the latest UK Review on Antimicrobial Resistance

- PMLiVE

Sobi launches disease awareness app with UK hospital

Pharma firm links with GOSH on helping children with haemophilia

- PMLiVE

Pharma ‘ignoring patient services’

New report finds industry should do more to make patients aware of therapeutic services

Eli Lilly HQ

Lilly and Sanford-Burnham reveal immunology collaboration

Will aim to discover and develop therapies in the field

- PMLiVE

Calchan names Zahid Ali as chief scientific officer

Ali joins from Pfizer where he was a senior director

- PMLiVE

AbbVie remains top of immunology sales

But the threat of biosimilars once again threatens to shake up the leader board

Pharma deals in April 2015

The love affair with oncology continues, finds Medius Deal Watch

Medius Deal Watch table for April 2015

The top major pharma mergers, acquisitions and collaborations during the month continued pharma's love affair with oncology

Roche Basel Switzerland

Roche moves closer to US filing for alectinib

Results showed alectinib able to shrink tumours in half of cases

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links